Ken Fisher Globe Star Therapeutics Corp Transaction History

Fisher Asset Management, LLC

  • $243 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$0.01 - $0.03 $450 - $1,350
-45,000 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$0.03 - $0.07 $1,350 - $3,150
45,000 New
45,000 $1,000

About GlobeStar Therapeutics Corp

GSTC Quotes by TradingView
  • Ticker GSTC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 693,996,992
  • Description
  • GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was...
More about GSTC
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email